Pillstats
Rx only · Injection · Intravenous

Eribulin Mesylate

Brands: Halaven · Eribulin Mesylate

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1045453
US makers13 labelers
Packages14
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2164336498662025 Q12025 Q22025 Q32025 Q42026 Q1
301
Rx · 2026 Q1
991
Units dispensed
-60%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Apotex Corp.unknown2SUPPLYING
Sandoz Incunknown1SUPPLYING
BSP Pharmaceuticals S.p.A.unknown1SUPPLYING
Baxter Healthcare Corporationunknown1SUPPLYING
Dr.Reddy's laboratories Limitedunknown1SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
XGen Pharmaceuticals DJB, Inc.unknown1SUPPLYING
Eisai Inc.unknown1SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown1SUPPLYING
Kindos Pharmaceuticals Co., Ltd.unknown1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.